YME borreliosis is a multisystem infectious disease caused by Borrelia burgdorferi. Involvement of the central nervous system is frequent in Lyme disease and may include encephalopathy or, less often, encephalomyelitis. 4, 5, 8 The diagnosis of neuroborreliosis is based on immunological tests. In the event of white matter involvement, however, differentiation of an infectious lesion from a brain tumor or demyelination remains difficult.
MR images ( Fig. 1 upper right and lower left ). An additional MR image of the neck (data not shown) demonstrated edema of the medulla oblongata extending into the proximal cervical spinal cord up to C2-3. Furthermore, results of this investigation revealed a contrast-enhancing diffuse lesion in the ventrocentral and dorsolateral left cervical spinal marrow. Subsequent serological tests, including those for herpes simplex, varicella-zoster virus, Treponema pallidum, and Listeria, were nondiagnostic. Antibodies against B. burgdorferi were elevated (IgM 1.1, IgG 2.7 [normal range Ͻ 0.8]) and the Lyme IgG titers measured using Western blot were slightly increased, thus indicating the inflammatory nature of the lesion.
Treatment. The patient was treated with Rocephin (2 g/ day) for 2 weeks. One week after initiating therapy the patient's state improved markedly and she experienced a striking recovery in motor function. When she was discharged, only a slight sensible spinal ataxia remained. Consequently, the serum Lyme IgM titer became negative whereas the IgG elevation persisted (2.2).
Posttreatment Course. The FDG-PET and MR imaging studies were repeated when the patient was in clinical remission 4 weeks after ending the antibiotic therapy. Visual analysis of the second PET study demonstrated no abnormalities in this region. In fact, the SUV max decreased to 4.5, whereas the MR image revealed a persisting signal hypodensity in the brainstem ( Fig. 1 lower center) . To illustrate the pre-and posttreatment effect further, subtraction of the normalized FDG-PET scans was performed. Results of this analysis revealed a marked increase in the glucose metabolism in the pretreatment study ( Fig. 1 lower right) .
Positron Emission Tomography and MR Imaging
At the initial PET study the patient presented in a fasting state with a glucose level of 75 mg/dl. A PET scan of the cranium was obtained during the first 60 minutes after the intravenous administration of 137 MBq FDG. The PET data were acquired on a unit (CTI ECAT EXACT HRϩ scanner; Siemens, Knoxville, TN) with a transaxial field of view of 10 cm and an in-plane resolution of 4.5 mm full width at half maximum in the center of the field of view. For further analysis, frames were summed from 30 to 60 minutes postinjection. For attenuation correction, transmission scans were acquired using a 68 Ge/ 68 Ga rod source. Transverse slices were reconstructed iteratively by using a Gauss-expectation maximization algorithm. A 256 ϫ 256 matrix was used for reconstruction. The reconstructed in-plane image resolution was 6.2 mm full width at half maximum. Data acquisition at the second FDG-PET session following successful treatment was performed in the same manner as in the first study. At this second session, the glucose level was 110 mg/dl while 133 MBq FDG was administered.
The high-resolution MR image was obtained on a 1.5-tesla MR imaging system (Siemens Magnetom Vision, Erlangen, Germany), using a T 1 -weighted three-dimensional magnetization-prepared rapid-acquisition gradient-echo sequence with TR 11.4 msec, TE 4.4 msec, TI 300 msec, field of view 217 mm, and matrix 200 ϫ 256 and a T 2 -weighted turbo-spin echo sequence with TR 5400 msec, TE 99 msec, flip angle 180˚, and matrix 198 ϫ 512. The PET scans were automatically coregistered with individual MR imaging data, normalized, and subtracted from each other by using commercially available software (MPI Tool; ATV, Inc., Kerpen, Germany).
Discussion
Acute myelitis caused by B. burgdorferi is rare. 6, 8 The clinical course of the disease can mimic a brain tumor, stroke, or demyelination process. [1] [2] [3] 5, 6 Apparently, morphological imaging is not helpful in differentiating these diagnoses. In those few published cases of Lyme myelitis, which have included MR imaging studies, the images demonstrated varied patterns of signal abnormality that did not contribute to the correct diagnosis. [1] [2] [3] 6 No PET data were available in these cases. Recently, an FDG-PET study revealed cerebral hypometabolism in patients suffering from neuroborreliosis, which was most pronounced in the temporal lobes. 7 Nevertheless, the authors found no pathognomonic pattern that would allow the diagnosis of neuroborreliosis.
Given the acute onset of the neurological symptoms in the patient in the present case, a malignant brainstem tumor was suspected initially. Results of an MR imaging study were inconclusive because the findings were compatible with both a brainstem tumor and a localized inflammatory process. On the first FDG-PET scan, malignancy was indicated based on increased glucose uptake in the brainstem lesion. Note, however, that the diagnosis of Lyme borreliosis was finally established by a positive index of specific IgM and IgG antibodies against B. burgdorferi and corroborated by a dramatic improvement in the patient's neurological symptoms and a decreasing IgM titer following antibiotic therapy. Confirmation of the diagnosis by CSF immunology was not prompted by the responsible physicians because the combination of the aforementioned criteria appeared reliable to establish the diagnosis of a neuroborreliosis. In addition, the decrease in FDG uptake on the second PET scan during clinical remission confirmed retrospectively the inflammatory nature of the lesion.
Thus MR imaging and FDG-PET were not helpful in the differentiation of a malignant and an inflammatory process in the brainstem at the onset of clinical symptoms. The limitation of FDG-PET in differentiating these processes is well known. An increased FDG uptake can often be demonstrated by inflammatory lesions, leading to false-positive interpretations of PET scans. 9, 10 In the case presented here, a pathological brainstem accumulation of FDG corresponded to a circumscribed Lyme borreliosis. In the absence of additional lesions, which would prompt the diagnosis of an inflammatory/infectious disease, the PET finding appeared to be a tumor and was therefore misleading for the primary diagnosis. During clinical follow up, however, FDG-PET studies appeared to be more useful than MR imaging. Although FDG uptake in the lesion reflected the clinical course (pre-and posttreatment period) of the infectious disease, the morphological changes as revealed on MR imaging persisted.
Conclusions
To the best of our knowledge, no other case of localized positive FDG-PET studies of neuroborreliosis has been reported so far. Our findings indicated that hypermetabolic findings on FDG-PET studies in the brainstem region should be regarded with caution, and neuroborreliosis must be considered as a possible differential diagnosis.
